Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANTHONY MARESSO and AUSTEN TERWILLIGER.
ANTHONY MARESSO
Connection Strength
5.552
AUSTEN TERWILLIGER
  1. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection. Viruses. 2021 10 12; 13(10).
    View in: PubMed
    Score: 0.724
  2. Tailored Antibacterials and Innovative Laboratories for Phage (F) Research: Personalized Infectious Disease Medicine for the Most Vulnerable At-Risk Patients. Phage (New Rochelle). 2020 06 01; 1(2):66-74.
    View in: PubMed
    Score: 0.659
  3. Bacillus anthracis Overcomes an Amino Acid Auxotrophy by Cleaving Host Serum Proteins. J Bacteriol. 2015 Jul; 197(14):2400-11.
    View in: PubMed
    Score: 0.464
  4. Pathogen-Phage Geomapping to Overcome Resistance. bioRxiv. 2025 Oct 01.
    View in: PubMed
    Score: 0.238
  5. Results of TOR001: An open-label single patient study using targeted bacteriophage therapy for the treatment of chronic urinary tract infection. Int J Antimicrob Agents. 2025 Dec; 66(6):107613.
    View in: PubMed
    Score: 0.237
  6. Phage-induced protection against lethal bacterial reinfection. Proc Natl Acad Sci U S A. 2025 Jun 03; 122(22):e2423286122.
    View in: PubMed
    Score: 0.233
  7. Sequencing-Based Detection of Avian Influenza A(H5N1) Virus in Wastewater in Ten Cities. N Engl J Med. 2024 09 26; 391(12):1157-1159.
    View in: PubMed
    Score: 0.222
  8. Wastewater sequencing reveals community and variant dynamics of the collective human virome. Nat Commun. 2023 10 28; 14(1):6878.
    View in: PubMed
    Score: 0.209
  9. A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes. Clin Infect Dis. 2023 10 13; 77(8):1079-1091.
    View in: PubMed
    Score: 0.208
  10. Class-Driven Synergy and Antagonism between a Pseudomonas Phage and Antibiotics. Infect Immun. 2023 08 16; 91(8):e0006523.
    View in: PubMed
    Score: 0.204
  11. Wastewater pandemic preparedness: Toward an end-to-end pathogen monitoring program. Front Public Health. 2023; 11:1137881.
    View in: PubMed
    Score: 0.200
  12. Discovery of the First Lytic Staphylococcus pseudintermedius/Staphylococcus aureus Polyvalent Bacteriophages. Phage (New Rochelle). 2022 Jun 01; 3(2):116-124.
    View in: PubMed
    Score: 0.189
  13. Metabolic profiling reveals nutrient preferences during carbon utilization in Bacillus species. Sci Rep. 2021 12 13; 11(1):23917.
    View in: PubMed
    Score: 0.183
  14. Loss of Dihydroxyacid Dehydratase Induces Auxotrophy in Bacillus anthracis. J Bacteriol. 2021 11 19; 203(24):e0041521.
    View in: PubMed
    Score: 0.181
  15. Antiviral Resistance and Phage Counter Adaptation to Antibiotic-Resistant Extraintestinal Pathogenic Escherichia coli. mBio. 2021 04 27; 12(2).
    View in: PubMed
    Score: 0.175
  16. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry. mBio. 2020 08 04; 11(4).
    View in: PubMed
    Score: 0.167
  17. Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model. Infect Immun. 2020 07 21; 88(8).
    View in: PubMed
    Score: 0.166
  18. Heme catabolism in the causative agent of anthrax. Mol Microbiol. 2019 08; 112(2):515-531.
    View in: PubMed
    Score: 0.154
  19. Progress toward the Development of a NEAT Protein Vaccine for Anthrax Disease. Infect Immun. 2016 Dec; 84(12):3408-3422.
    View in: PubMed
    Score: 0.129
  20. Iron and zinc exploitation during bacterial pathogenesis. Metallomics. 2015 Dec; 7(12):1541-54.
    View in: PubMed
    Score: 0.120
  21. Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. Infect Immun. 2026 Apr 15; 94(4):e0054325.
    View in: PubMed
    Score: 0.061
  22. Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. bioRxiv. 2025 Oct 06.
    View in: PubMed
    Score: 0.060
  23. Present and future of microbiome-targeting therapeutics. J Clin Invest. 2025 Jun 02; 135(11).
    View in: PubMed
    Score: 0.058
  24. A Case of Persistent Intra-Abdominal Stenotrophomonas maltophilia Infection Despite Bacteriophage Therapy. Phage (New Rochelle). 2024 Sep; 5(3):120-125.
    View in: PubMed
    Score: 0.055
  25. Assessment of a SARS-CoV-2 wastewater monitoring program in El Paso, Texas, from November 2020 to June 2022. Int J Environ Health Res. 2024 Jan; 34(1):564-574.
    View in: PubMed
    Score: 0.049
  26. Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in the Galleria mellonella Wax Moth Larvae Model. Pharmaceutics. 2022 Jul 30; 14(8).
    View in: PubMed
    Score: 0.048
  27. Identifying Causative Microorganisms in Left Ventricular Assist Device Infections as a Guide for Developing Bacteriophage Therapy. J Surg Res. 2022 03; 271:73-81.
    View in: PubMed
    Score: 0.046
  28. Evaluating recovery, cost, and throughput of different concentration methods for SARS-CoV-2 wastewater-based epidemiology. Water Res. 2021 Jun 01; 197:117043.
    View in: PubMed
    Score: 0.043
  29. Constructing and Characterizing Bacteriophage Libraries for Phage Therapy of Human Infections. Front Microbiol. 2019; 10:2537.
    View in: PubMed
    Score: 0.040
  30. Structure of the Bacillus anthracis Sortase A Enzyme Bound to Its Sorting Signal: A FLEXIBLE AMINO-TERMINAL APPENDAGE MODULATES SUBSTRATE ACCESS. J Biol Chem. 2015 Oct 16; 290(42):25461-74.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.